comparemela.com

Page 7 - American Thoracic Society International Conference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss of Control Events in Patients With Asthma

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.

High HbA1c levels associated with poor asthma control in children

SAN DIEGO — High HbA1c levels consistent with prediabetes were associated with worse asthma control in a population of urban children, according to a presentation at the American Thoracic Society International Conference. Previous studies have indicated that insulin resistance may influence asthma morbidity, Hewlett Pham, BS, research program assistant, pulmonary and critical care medicine,

Sanofi and Regeneron share positive late-stage results for Dupixent in COPD

Targeted lung denervation lowers COPD exacerbations, improves quality of life over 2 years

SAN DIEGO — Patients with COPD treated with targeted lung denervation along with optimal COPD therapy experienced fewer exacerbations over 2 years, according to research presented at the American Thoracic Society International Conference.Targeted lung denervation (Nuvaira Inc.) has “only [been] done in research setting to date,” Gerard J. Criner, MD, FACP, FACCP, chair and

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.